SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-042654
Filing Date
2017-08-14
Accepted
2017-08-14 08:31:24
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v472296_10q.htm 10-Q 237410
2 EXHIBIT 10.1 v472296_ex10-1.htm EX-10.1 13399
3 EXHIBIT 31.1 v472296_ex31-1.htm EX-31.1 10459
4 EXHIBIT 31.2 v472296_ex31-2.htm EX-31.2 10440
5 EXHIBIT 32.1 v472296_ex32-1.htm EX-32.1 4514
  Complete submission text file 0001144204-17-042654.txt   2952574

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clrb-20170630.xml EX-101.INS 657016
7 XBRL TAXONOMY EXTENSION SCHEMA clrb-20170630.xsd EX-101.SCH 32540
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clrb-20170630_cal.xml EX-101.CAL 24609
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20170630_def.xml EX-101.DEF 206898
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20170630_lab.xml EX-101.LAB 248277
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20170630_pre.xml EX-101.PRE 230355
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 171027355
SIC: 2834 Pharmaceutical Preparations